Zeyad Khalaf, Global Medical Director, Haematology at GSK shared a post on LinkedIn:
“Incredible time in Whistler for the 13th Whistler Summit on Hematologic Malignancies!
A huge thank you to the organizers at DAVA Oncology for inviting me to present on GSK’s hematology pipeline. It was a fantastic opportunity to discuss our efforts and share updates with such an esteemed group of peers on GSKs global medical affairs studies in plasma cell disorders.
The meeting was highly engaging, full of deep insights and valuable discussions on advancing hematological care.
I enjoyed connecting with experts in the field and discussing the future of this rapidly evolving landscape!”
Other articles about Hematology on OncoDaily.